STUDIES FOR THE MECHANISM OF MULTIPLICITY IN SUBSTRATE SPECIFICITY OF TRANSPORTERS.
STUDIES FOR THE MECHANISM OF MULTIPLICITY IN SUBSTRATE SPECIFICITY OF TRANSPORTERS.
批准号:
13470513
负责人:
TAMAI Ikumi
金额:
$8.32万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
药代动力学特性对药物治疗具有重要意义,受结合蛋白、药物代谢酶和膜转运蛋白等多种因素的影响。其中,药物转运体对药物的肠道吸收、组织分布以及肝脏和肾脏排泄具有重要作用。因此,哪种药物被接受为每种转运体的底物将是重要的。然而,一些药物转运体接受多种化合物作为底物,其多特异性机制尚未明确。有机阳离子/肉毒碱转运体OCTN和有机阴离子转运多肽otp - c也接受多种生理和药物化合物作为底物。在本研究中,我们通过关注moctn转运肉碱作为生理底物和阳离子化合物的多功能性来研究这些转运体识别底物的多特异性机制。OCTN在转运肉碱时,完全依赖Na^+,而有机阳离子如四乙基铵(TEA)的转运则不依赖Na^+。利用OCTN突变蛋白的研究表明,肉碱和TEA在OCTN2上部分共享底物识别位点,但它们并不完全相同。Na^+在很大程度上影响了肉碱对OCTN2的亲和力,而TEA对Na^+对OCTN2的亲和力没有影响。然而,肉碱和茶表现出相互抑制作用,但不能用完全竞争抑制动力学来解释。肉毒碱与TEA之间转运机制的差异可以解释为肉毒碱特有的羧基片段的存在,Na^+影响肉毒碱羧基片段与OCTN2蛋白之间的相互作用。这些观察结果表明,OCTN的多特异性是由于OCTN的多功能性,根据底物改变转运机制,至于驱动力Na^+。因此,阐明转运蛋白对每种底物的驱动力对于阐明转运蛋白的多特异性机制具有重要意义。就OATP而言,目前还没有明确的驱动力证明,而OATP接受各种化合物作为底物。为了阐明OATP多特异性的机制,在未来的研究中,有必要确定每种底物的驱动力
英文摘要
Pharmacokinetic characteristics are important for the adequate drug therapy and they are affected by many factors, including binding proteins, drug metabolizing enzymes and membrane transporters. Among them, drug transporter are important for the intestinal absorption, tissue distribution, and hepatic and renal excretion of drugs. Accordingly, it will be important what kinds of drugs are accepted as substrates for each transporter. However, some drug transporters accept various compounds as substrates and it has not been clarified the mechanism for such multispecificity of drug transporterOrganic cation/carnitine transporter OCTN and organic anion transporting polypeptide OATP-C also accept various physiological and drug compounds as substrates. In the present study, we studied the mechanism for the multispecificity in the substrate recognition of those transporters by focusing on the multifunctionality of themOCTN transports carnitine as physiological substrates and cationic compounds … More as xenobiotics. When OCTN transports carnitine, it exclusively shows Na^+-dependence, while the transport of organic cation such as tetraethylammonium (TEA) is Na^+-independent. The study using mutant protein of OCTN exhibited that carnitne and TEA partially shares the substrate recognition sites on OCTN2, while they are not identical. Na^+ largely affect the affinity of carnitine to OCTN2, while TEA did not show any change in the affinity to OCTN2 by Na^+. However, carnitine and TEA exhibited mutual inhibitory effect, while they are not explained by complete competitive inhibition kinetics. The difference in the transporting mechanism between carnitine and TEA could be explained by the presence of the carboxylmoiety that is specific for carnitine and the Na^+ affect the interaction between carboxylmoiety of carnitine and OCTN2 protein. These observations suggested that multispecificity of OCTN is due to the multifunctionality of OCTN by changing the transport mechanisms depending on the substrates, regarding the driving force, Na^+. Accordingly, clarification of the driving force of the transporter for each substrate is important to clarify the mechanism of multispecificity of transporters. In the case of OATP, at present no driving force has been clearly demonstrated, while OATP accept various compounds as substrates. To clarify the mechanism for the multispecificity of OATP, it will be essential to identify the driving force for each substrate in future Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nozawa T., Nakajima M., Tamai I., Noda K., Nezu J., Sai Y., Tuji A.: "Genetic polymorphism of human organic anion transporter OATP-C(SLC21A6) and OATP-B(SLC21A9) : Allele frequencies in the Japanese population and functional"Journal of Pharmacology and Ex
Nozawa T.、Nakajima M.、Tamai I.、Noda K.、Nezu J.、Sai Y.、Tuji A.:“人类有机阴离子转运蛋白 OATP-C(SLC21A6) 和 OATP-B(SLC21A9) 的基因多态性:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamai I. China K., Sai Y., Kobayashi D., Nezu J., Kawahara E., Tsuji A. 0277032GB02 Na^+-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization.: "Na+-coupled transport of L-carnitine via high-affin
Tamai I. China K.,Sai Y.,Kobayashi D.,Nezu J.,Kawahara E.,Tsuji A. 0277032GB02 Na^-通过高亲和力肉碱转运蛋白 OCTN2 进行左旋肉碱耦合转运及其亚细胞定位。:“
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nozawa T., Tamai I., Sai Y., Nezu J., Tsuji A.: "Contribution of organic anikon transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide [D-Ala^2, D-Lue^5]enkephalin"Journal of Pharmacy and Pharmacology. (in press). (2003)
Nozawa T.、Tamai I.、Sai Y.、Nezu J.、Tsuji A.:“有机 anikon 转运多肽 OATP-C 对肝脏消除阿片类五肽的贡献 [D-Ala^2、D-Lue^5]
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nozawa T., Nakajima M., Tamai I., Noda K., Nezu J., Sai Y., Tsuji A., Yokoi T.: "Genetic polymorphism of human organic anion transporter OATP-C (SLC21A6) and OATP-B (SLC21A9) : Allele frequencies in the Japanese population and functional analysis"J. Pharm
Nozawa T.、Nakajima M.、Tamai I.、Noda K.、Nezu J.、Sai Y.、Tsuji A.、Yokoi T.:“人类有机阴离子转运蛋白 OATP-C (SLC21A6) 和 OATP-B 的基因多态性
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ikumi Tamai: "Functional characterization of human organic aniors thimipatihg polypeptide B(OATP-B)in comparison with liver specific OATR-C"Pharmaceutical Research. 18・9. 1262-1269 (2001)
Ikumi Tamai:“与肝脏特异性 OATR-C 相比的人类有机阴离子 thimipatihg 多肽 B(OATP-B) 的功能表征”,Pharmaceutical Research 18・9 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Application of Sandwich-cultured hepatocytes for analysis of drug-drug interaction on bile canalicular transporters
-
批准号:23659076
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TAMAI Ikumi
-
依托单位:
Clarification and evaluation of regulation mechanism of uric acid
-
批准号:21390044
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2009
-
负责人:TAMAI Ikumi
-
依托单位:
Species difference in hepatic disposition of organic anions
-
批准号:19390046
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2007
-
负责人:TAMAI Ikumi
-
依托单位:
Establishment of Novel Anti-Hormone Therapy of Breast Cancer based on the Inhibition of Uptake Transporter of Conjugated Estrogen by Cancer Cells.
-
批准号:17390046
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2005
-
负责人:TAMAI Ikumi
-
依托单位:
Drug Toxicity Induced by Alteration of Transporter Activity
-
批准号:15390051
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.6万
-
财政年份:2003
-
负责人:TAMAI Ikumi
-
依托单位:
Evaluation of the blood-brain barrier based on the functional analysis of transporters using newly developed techniques.
-
批准号:12557229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.44万
-
财政年份:2000
-
负责人:TAMAI Ikumi
-
依托单位:
Functional characterization and relevance of carnitine transporter OCTN2 to secondary carnitine deficiency.
-
批准号:11672212
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:TAMAI Ikumi
-
依托单位:
Molecular mechanism of blood-brain barrier transport of drugs.
-
批准号:09672221
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:TAMAI Ikumi
-
依托单位:
海外基金